Boasting extensive experience in managing investments within the life sciences and technology sectors, the fund manager has successfully executed over 50 deals across various stages, including early and growth investments. Their strategic approach is characterized by a data-driven methodology, aligning closely with market trends to identify high-potential opportunities. With a strong presence in both North America and Europe, notable exits have consistently highlighted their ability to navigate complex investment landscapes effectively. This operator-first style emphasizes collaboration with portfolio companies to drive innovation and growth.